investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
Ronald G Blasberg
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ronald G Blasberg
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Adam De La Zerda
Molecular Imaging of Protein Glycosylation in Living Subjects
Prostate
Matthew L Freedman
Defining the epigenetic landscape in human prostate cancer
Prostate
Pathology
Thomas M Roberts
Targeting the p110beta isoform of PI3 kinase in prostate cancer
Prostate
Marja T Nevalainen
Stat5 in Progression of Prostate Cancer
Prostate
Pathology
Harry Ostrer
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
Prostate
Timothy Rebbeck
Men of African Descent and Carcinoma of the Prostate (MADCaP)
Prostate
Pathology
Antonio Fojo
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
Prostate
Charles L. Sawyers
Understanding Resistance to Next Generation Antiandrogens
Prostate
Peter B Dervan
Programmable DNA Binding Oligomers for Control of Transcription
Prostate